Liquid Biopsy Market
Liquid Biopsy Market
The global liquid biopsy market size is projected to reach USD 23.94 billion by 2034, growing from USD 7.08 billion in 2025, at a CAGR of 14.5% during the forecast period from 2025 to 2034, as a result of technological advancements in cancer diagnostics, and rising preference for minimally invasive cancer diagnostics.
Report ID: 10030
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 6.18 Bn
Forecast Year,
USD USD 23.94 Bn
CAGR, 2025 -
14.5%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Liquid Biopsy Market Size Analysis
Liquid Biopsy Market Size By Sample Type 2024 to 2034 (USD )
| Sample Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood Sample | 5253.00 | 6011.15 | 6878.71 | 7871.49 | 9007.54 | 10307.55 | 11795.19 | 13497.52 | 15445.53 | 17674.68 | 20225.54 |
| Others | 927.00 | 1064.95 | 1223.42 | 1405.46 | 1614.56 | 1854.75 | 2130.65 | 2447.57 | 2811.60 | 3229.73 | 3710.01 |
Liquid Biopsy Market Size By Biomarker 2024 to 2034 (USD )
| Biomarker | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Circulating Tumor Cells (CTCs) | 2163.00 | 2480.17 | 2843.85 | 3260.85 | 3738.98 | 4287.21 | 4915.82 | 5636.59 | 6463.02 | 7410.61 | 8497.12 |
| Circulating Nucleic Acids | 1854.00 | 2120.71 | 2425.78 | 2774.73 | 3173.88 | 3630.45 | 4152.69 | 4750.04 | 5433.32 | 6214.88 | 7108.86 |
| Exosomes/ Microvesicles | 1236.00 | 1416.64 | 1623.67 | 1860.95 | 2132.92 | 2444.62 | 2801.88 | 3211.34 | 3680.64 | 4218.51 | 4834.98 |
| Circulating Proteins | 927.00 | 1058.58 | 1208.84 | 1380.41 | 1576.32 | 1800.02 | 2055.45 | 2347.12 | 2680.15 | 3060.41 | 3494.59 |
Liquid Biopsy Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Multi-gene-parallel Analysis (NGS) | 4326.00 | 4956.10 | 5677.98 | 6504.99 | 7452.47 | 8537.94 | 9781.51 | 11206.21 | 12838.41 | 14708.34 | 16850.62 |
| Single Gene Analysis (PCR Microarrays) | 1854.00 | 2120.00 | 2424.16 | 2771.95 | 3169.63 | 3624.37 | 4144.33 | 4738.88 | 5418.71 | 6196.07 | 7084.92 |
Liquid Biopsy Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 4635.00 | 5304.95 | 6071.74 | 6949.36 | 7953.83 | 9103.49 | 10419.31 | 11925.33 | 13649.03 | 15621.86 | 17879.85 |
| Reproductive Health | 927.00 | 1062.83 | 1218.56 | 1397.11 | 1601.81 | 1836.51 | 2105.59 | 2414.09 | 2767.78 | 3173.29 | 3638.20 |
| Others | 618.00 | 708.32 | 811.83 | 930.48 | 1066.46 | 1222.31 | 1400.94 | 1605.67 | 1840.32 | 2109.25 | 2417.49 |
Liquid Biopsy Market Size By Clinical Application 2024 to 2034 (USD )
| Clinical Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Therapy Selection | 1545.00 | 1770.44 | 2028.77 | 2324.80 | 2664.02 | 3052.74 | 3498.17 | 4008.59 | 4593.49 | 5263.73 | 6031.76 |
| Treatment Monitoring | 1236.00 | 1414.51 | 1618.81 | 1852.61 | 2120.17 | 2426.38 | 2776.81 | 3177.86 | 3636.82 | 4162.07 | 4763.17 |
| Early Cancer Screening | 1112.40 | 1274.41 | 1460.00 | 1672.63 | 1916.23 | 2195.30 | 2515.01 | 2881.28 | 3300.89 | 3781.61 | 4332.33 |
| Recurrence Monitoring | 1050.60 | 1203.29 | 1378.17 | 1578.47 | 1807.88 | 2070.63 | 2371.57 | 2716.25 | 3111.01 | 3563.16 | 4081.01 |
| Others | 1236.00 | 1413.45 | 1616.38 | 1848.43 | 2113.80 | 2417.26 | 2764.28 | 3161.11 | 3614.91 | 4133.85 | 4727.27 |
Liquid Biopsy Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 1236.00 | 1413.10 | 1615.57 | 1847.04 | 2111.67 | 2414.22 | 2760.10 | 3155.53 | 3607.61 | 4124.44 | 4715.30 |
| Consumables Kits and Reagents | 4017.00 | 4601.59 | 5271.25 | 6038.36 | 6917.11 | 7923.74 | 9076.86 | 10397.79 | 11910.95 | 13644.31 | 15629.91 |
| Software and Services | 927.00 | 1061.42 | 1215.32 | 1391.54 | 1593.32 | 1824.35 | 2088.88 | 2391.76 | 2738.57 | 3135.66 | 3590.33 |
Liquid Biopsy Market Size By End-Use 2024 to 2034 (USD )
| End-Use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals and Laboratories | 3090.00 | 3536.63 | 4047.83 | 4632.91 | 5302.55 | 6068.99 | 6946.21 | 7950.22 | 9099.35 | 10414.58 | 11919.90 |
| Specialty Clinics | 1545.00 | 1770.44 | 2028.77 | 2324.80 | 2664.02 | 3052.74 | 3498.17 | 4008.59 | 4593.49 | 5263.73 | 6031.76 |
| Academic and Research Centers | 927.00 | 1061.77 | 1216.13 | 1392.93 | 1595.44 | 1827.39 | 2093.05 | 2397.34 | 2745.87 | 3145.07 | 3602.30 |
| Others | 618.00 | 707.26 | 809.40 | 926.30 | 1060.09 | 1213.19 | 1388.41 | 1588.93 | 1818.41 | 2081.03 | 2381.59 |
Liquid Biopsy Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2472.00 | 2829.02 | 3237.61 | 3705.21 | 4240.34 | 4852.76 | 5553.62 | 6355.71 | 7273.64 | 8324.13 | 9526.35 |
| Europe | 1545.00 | 1768.32 | 2023.91 | 2316.45 | 2651.28 | 3034.50 | 3473.10 | 3975.11 | 4549.68 | 5207.29 | 5959.95 |
| Asia-Pacific | 1359.60 | 1558.51 | 1786.52 | 2047.89 | 2347.48 | 2690.91 | 3084.57 | 3535.82 | 4053.08 | 4646.00 | 5325.66 |
| Latin America | 432.60 | 495.50 | 567.55 | 650.08 | 744.61 | 852.88 | 976.90 | 1118.95 | 1281.65 | 1468.01 | 1681.47 |
| Middle East & Africa | 370.80 | 424.74 | 486.53 | 557.31 | 638.39 | 731.26 | 837.64 | 959.50 | 1099.08 | 1258.97 | 1442.12 |
Liquid Biopsy Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
